儿科功能性发作:人口统计,临床和心理特征以及危险因素
Sherifa Ahmed Hamed1, Ali Farrag ElHadad2, Mohamed Fawzy1
1Department of Neurology and Psychiatry, Assiut University Hospital, Assiut, Egypt.
Epilepsy & behavior : E&B
|February 17, 2026
概括
儿科功能性发作 (FS),也称为心理性非发作 (PNES),在诊所中很常见,影响大约15%的患者. 早期诊断和FS的管理对于预防长期的发育问题至关重要.
科学领域:
- 神经学 神经学
- 儿科 儿科 儿科
- 精神病学是一个精神病学.
背景情况:
- 与成人群体相比,儿科功能性 (FS) 或精神性非性 (PNES) 的研究不足.
- 了解儿科FS的患病率,临床特征和预测因素对于改善患者的治疗结果至关重要.
研究的目的:
- 为了确定儿童诊所FS的患病率.
- 调查与儿科FS相关的临床模式,行为特征和风险预测因素.
主要方法:
- 患者从门诊儿科诊所招募.
- 数据包括人口统计,临床特征,视频脑电图,精神病学访谈和心理测量问卷 (儿童行为检查清单).
主要成果:
- 在儿科临床中,FS的患病率为15.42%;5.14%的人患有混合和FS.
- FS主要影响青少年 (66.7%),平均年龄为14岁,诊断延迟范围为4-14个月.
- 与对照组和患者相比,FS患者在儿童行为检查清单 (焦虑,体化,注意力不集中) 和内化/外化行为问题上表现出更高的分数.
结论:
- 功能性发作是儿科诊所常见的诊断,经常被误诊为.
- 心理社会因素,如自我效能冲突和学校/家庭问题是FS的重要预测因素.
- 及时诊断和管理儿科FS至关重要,以减轻对人格,社会互动和学业表现的负面影响.
相关概念视频
Seizures: Classification
1.7K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
Epilepsy and Seizures: Overview
1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
258
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
334
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
334
Attention-Deficit/Hyperactivity Disorder
1.1K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution
338
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338


